OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeting opioid dysregulation in depression for the development of novel therapeutics

HTML

Year: 2019
Type: review
Source: Pharmacology & Therapeutics
DOI: 10.1016/j.pharmthera.2019.04.009
Authors: Caroline A. Browne, Irwin Lucki
Institution: Uniformed Services University of the Health Sciences
Language: English

Topic: Neuropeptides and Animal Physiology
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: major depressive disorder, endogenous opioids, endorphins, enkephalin, dynorphin, nociceptin/orphanin FQ, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, NOP receptor, antidepressant resistance
SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Mental Health
Awards: Buprenorphine for Depression and Anxiety, Kappa Receptor Antagonists as Rapid Acting Antidepressants
OpenAlex ID: W2942936997
FWCI: 1.377
Cites: 435
Cited by: 103
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security